Physician profile
Michael D Vardy
NPI 1710925078
$113,760.72
in general payments reported to CMS, 2019-2025
17 companies · $206 in 2025
The $206 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48K · 2020: $15K · 2021: $26K · 2022: $23K · 2023: $1,025 · 2024: $344 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $900 · Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $900.00 |
| Food and Beverage | $674.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $111,463.44 | 2019-2022 | |
| Ibsa Pharma INC. | $1,025.00 | 2023 | Tirosint |
| Escala Medical INC. | $515.97 | 2024-2025 | |
| Coloplast Corp | $252.21 | 2020-2022 | |
| Axonics, INC. | $139.84 | 2020-2021 | |
| Caldera Medical, INC | $83.98 | 2022 | |
| Medtronic USA, INC. | $52.88 | 2019-2020 | |
| Allergan, INC. | $50.08 | 2019 | |
| Medtronic, INC. | $46.15 | 2021-2022 | |
| Davol INC. | $24.92 | 2022 | |
| Avanos Medical | $20.95 | 2020 | |
| Smith+Nephew, INC. | $20.78 | 2025 | Pico 14 |
| Therapeuticsmd, INC. | $13.47 | 2019 | |
| Astellas Pharma US INC | $13.33 | 2019 | |
| Organon LLC | $13.22 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $12.67 | 2019 | |
| Minerva Surgical, INC | $11.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Vardy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.